Logged in as: Guest

Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis

14 Apr 2024 04:00 pm 04:30 pm
Spotlight Stage 1 (exhibition hall)
BradRovin Spotlight Speaker The Ohio State UniversityUnited States
UptalPatel Spotlight Speaker United States
Add to My Schedule
  1. Rationale for anti-CD38 therapy in Lupus Nephritis
  2. Overview of Felzartamab and current Ph1b Lupus Nephritis trial design